Kezar Life Sciences, Inc.
KZR
$4.50
$0.102.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 132.25M | 148.39M | 164.18M | 179.80M | 201.37M |
| Total Receivables | 424.00K | 1.09M | 1.69M | 3.06M | 2.29M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.09M | 1.44M | 766.00K | 1.03M | 1.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.73M | 5.46M | 983.00K | 1.74M | 2.07M |
| Total Current Assets | 137.49M | 156.38M | 167.62M | 185.61M | 206.95M |
|
|
|||||
| Total Current Assets | 137.49M | 156.38M | 167.62M | 185.61M | 206.95M |
| Net Property, Plant & Equipment | 4.78M | 5.29M | 5.78M | 8.02M | 8.69M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.42M | 2.42M | 6.52M | 5.50M | 5.60M |
| Total Assets | 144.68M | 164.09M | 179.92M | 199.13M | 221.24M |
|
|
|||||
| Total Accounts Payable | 3.65M | 3.46M | 2.26M | 5.06M | 8.25M |
| Total Accrued Expenses | 7.94M | 9.66M | 9.36M | 6.66M | 6.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.74M | 7.30M | 5.87M | 4.44M | 3.01M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 20.33M | 20.43M | 17.50M | 16.16M | 17.74M |
|
|
|||||
| Total Current Liabilities | 20.33M | 20.43M | 17.50M | 16.16M | 17.74M |
| Long-Term Debt | 5.11M | 6.35M | 7.59M | 8.83M | 10.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.33M | 3.26M | 4.15M | 5.02M | 5.85M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 27.77M | 30.04M | 29.24M | 30.01M | 33.67M |
|
|
|||||
| Common Stock & APIC | 551.58M | 548.22M | 545.04M | 541.90M | 538.46M |
| Retained Earnings | -434.50M | -414.28M | -393.97M | -372.42M | -350.76M |
| Treasury Stock & Other | -162.00K | 107.00K | -385.00K | -355.00K | -130.00K |
| Total Common Equity | 116.92M | 134.05M | 150.69M | 169.12M | 187.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 116.92M | 134.05M | 150.69M | 169.12M | 187.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 116.92M | 134.05M | 150.69M | 169.12M | 187.57M |
|
|
|||||